Photoleukomelanodermatitis of Kobori

In today's world, Photoleukomelanodermatitis of Kobori has acquired unprecedented relevance. Whether in the field of science, technology, art, politics or everyday life, Photoleukomelanodermatitis of Kobori is a topic that has captured the attention of millions of people around the world. Its impact has been felt significantly in our lives, generating debates, controversies and discoveries that have transformed our perception and understanding of Photoleukomelanodermatitis of Kobori. In this article, we will explore this phenomenon in depth, analyzing its various facets, its history, its current influence and its future potential.

Medical condition

Photoleukomelanodermatitis of Kobori
Specialty	Dermatology

Photoleukomelanodermatitis of Kobori is a cutaneous condition, a dyschromic drug eruption that occurs after ingestion of afloqualone, thiazides or tetracyclines, followed by exposure to sunlight.

See also

• Leukotriene receptor antagonist-associated Churg–Strauss syndrome
• List of cutaneous conditions

References

1. ^ Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN 978-1-4160-2999-1.

This cutaneous condition article is a stub. You can help Wikipedia by expanding it.

• v
• t
• e